Pricing Log in Create free account

NanoViricides, Inc. (NNVC) vs Pelthos Therapeutics Inc. (PTHS)

NanoViricides, Inc. and Pelthos Therapeutics Inc. are both Biotechnology companies. NanoViricides, Inc. and Pelthos Therapeutics Inc. are of similar size ($35.6M and $32.9M). NanoViricides, Inc. has the higher net margin (0.00% vs −199.5%) and the lower return on invested capital (−88.2% vs −82.3%). Across the 13 metrics below, NanoViricides, Inc. leads on 8 and Pelthos Therapeutics Inc. on 5.

Valuation

Metric NNVC PTHS Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.78 9.40
P/B 3.09 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.88 9.02
Earnings yield (30.08%) (276.23%) (32.88%)
Free cash flow yield (28.98%) (126.55%) (23.13%)

Profitability

Metric NNVC PTHS Biotechnology median
Gross margin 0.00% 78.59% 68.51%
Operating margin 0.00% (133.42%) 0.00%
Net margin 0.00% (199.50%) 0.00%
Free cash flow margin 0.00% (98.37%) 0.00%
Return on equity (101.46%) 2,161.07% (51.96%)
Return on assets (87.91%) (125.04%) (46.06%)
Return on invested capital (88.16%) (82.34%) 0.00%

Growth

Metric NNVC PTHS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 34.92% (61.12%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NNVC PTHS Biotechnology median
Debt to equity 0.00 (46.58) 0.00
Current ratio 2.66 1.98 4.97
Net debt to EBITDA 0.36 (0.45) 1.01

Dividend

Metric NNVC PTHS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NNVC PTHS Biotechnology median
Market cap 32.92m 35.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack